Table 3.

Genetic Disorders to Consider in the Differential Diagnosis of Phosphorylase Kinase (PhK) Deficiency

PhK Deficiency
Type
DisorderMOIOverlapping FeaturesDistinguishing FeaturesGene(s)Enzyme
Liver PhK
deficiency
Glycogen storage disease type VI ARClinical features can be indistinguishable.In liver PhK deficiency: low liver glycogen phosphorylase activity on in vitro assay 1 PYGL Glycogen phosphorylase, liver form
Glycogen storage disease type I
(GSD I)
AR
  • Hepatomegaly
  • Hypoglycemia
In GSD I:
  • Severe fasting lactic acidosis
  • Hyperuricemia
  • Significant hyperlipidemia
  • Neutropenia
In PhK deficiency: ketosis usually present
G6PC1,
SLC37A4
  • Glucose-6-phosphatase
  • Glucose-6-phosphate exchanger SLC37A4
Glycogen storage disease type III
(GSD III)
AR
  • Hepatomegaly
  • Hyperlipidemia
  • Hypoglycemia & ketosis
In GSD III: hypoglycemia more severe & muscle involvement w/↑ CK concentrations AGL Glycogen-debranching enzyme
Glycogen storage disease type IV (GSD IV)AR
  • Hepatomegaly
  • Liver cirrhosis
  • Liver dysfunction
In GSD IV:
  • Hypoglycemia & ketosis not typically seen
  • No hypoglycemia in initial stages
  • Accumulation of an abnormal glycogen (amylopectin) in liver & other tissues
GBE1 1,4-alpha-glucan-branching enzyme
Fructose-1,6-bisphosphatase deficiency (Note: Other disorders of gluconeogenesis can also be considered. 2)AR
  • ↑ uric acid, AST, ALT
  • Fasting hypoglycemia & hyperlacticacidemia
  • Hepatomegaly
In disorders of gluconeogenesis: hypoglycemia after more prolonged (e.g., overnight) fasting or during intercurrent illness w/↓ carbohydrate intake FBP1 Fructose-1,6-bisphosphatase 1
Alpha-1 antitrypsin deficiency 3AR
  • ↑ AST, ALT
  • Hepatomegaly
In alpha-1-antitrypsin deficiency: lack of fasting hypoglycemia & hyperlacticacidemia SERPINA1 Alpha-1 antitrypsin
Deoxyguanosine kinase deficiency (mitochondrial DNA depletion syndrome 3)AR
  • Hepatomegaly
  • Hypoglycemia
In deoxyguanosine kinase deficiency:
  • Neurologic abnormalities
  • Lactic acidosis
DGUOK Mitochondrial respiratory chain complexes (I, III, IV, V)
Mitochondrial complex V (ATP synthase) deficiency (OMIM 604273)ARHepatomegalyIn mitochondrial complex V deficiency:
  • Ataxia
  • Lactic acidosis
ATPAF2 ATP synthase
Glycerol kinase deficiency (OMIM 307030)XLHypoglycemiaIn glycerol kinase deficiency:
  • Ketoacidosis
  • Extremely elevated glycerol
GK Glycerol kinase
Niemann-Pick disease type B 4 (See Acid Sphingomyelinase Deficiency.)AR
  • Growth restriction
  • Hepatomegaly
  • Hyperlipidemia
In Niemann-Pick disease type B:
  • Lack of fasting hypoglycemia
  • Significant splenomegaly
  • Storage cells characteristic of disease
  • Other features incl bone & pulmonary involvement
SMPD1 Sphingomyelin phosphodiesterase
Gaucher disease 4ARHepatomegalyIn Gaucher disease:
  • Lack of fasting hypoglycemia
  • Significant splenomegaly
  • Storage cells characteristic of the disease
  • Other features incl bone involvement
  • Early-onset thrombocytopenia
GBA Glucosylceramidase
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency 5 (See Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency / Trifunctional Protein Deficiency.)AR
  • Hepatomegaly
  • Hypoglycemia
In LCHAD deficiency:
  • Cardiomyopathy
  • Peripheral neuropathy
  • Retinopathy
HADHA Trifunctional enzyme subunit alpha, mitochondrial
Fanconi-Bickel syndrome (OMIM 227810)AR
  • Hepatomegaly
  • Hypoglycemia
In Fanconi-Bickel syndrome:
  • Splenomegaly
  • Rickets
  • Renal tubular dysfunction
  • Hyperphosphatemia
SLC2A2 Solute carrier family 2, facilitated glucose transporter member 2
Liver PhK
deficiency &
Muscle PhK
deficiency
VLCAD deficiency AR
  • Exercise intolerance
  • Hepatomegaly
  • Hypoglycemia
  • Hypotonia
  • Muscle cramps
  • Muscle pain
In early-onset form of VLCAD deficiency:
  • Hypoketosis
  • Cardiomyopathy
  • Pericardial effusion
Disorders distinguished by enzymatic &
molecular genetic testing
ACADVL Very long-chain specific acyl-CoA dehydrogenase, mitochondrial
Muscle PhK
deficiency
Glycogen storage disease type V
(GSD V) 6
AR
  • Cramps
  • Exercise intolerance
  • Fatigue
  • Muscle weakness
  • Myalgia
  • Myoglobinuria
  • Poor endurance
In GSD V: "second-wind" phenomenon PYGM Glycogen phosphorylase, muscle form
Glycogen storage disease type VII (GSDVII) 7
(OMIM 232800)
AR
  • Exercise intolerance
  • Fatigue
  • Muscle cramps
In GSD VII:
  • Compensated hemolysis
  • Hyperuricemia
PFKM ATP-dependent 6-phosphofructokinase, muscle type
Mitochondrial myopathySee
footnote
8.
  • Hypoglycemia
  • Muscle weakness
  • Exercise intolerance
In mitochondrial myopathy:
  • Ragged red fibers
  • Multisystem involvement incl: abnormal eye movements, ptosis, optic neuropathy; epilepsy; sensorineural hearing loss; lactic acidemia
See footnote 8.See footnote 8.
Myoadenylate deaminase deficiency (OMIM 615511)ARExercise-induced myalgia, rhabdomyolysis, &/or ↑ serum CKDisorders distinguished by enzymatic &
molecular genetic testing
AMPD1 AMP deaminase 1
Carnitine palmitoyltransferase II deficiency AR
  • ↑ hepatic transaminases
  • Hepatomegaly
  • Hypoglycemia
  • Myalgia
  • Myoglobinuria
In CPT II deficiency:
  • Hypoketosis
  • Cardiomyopathy
  • Arrhythmia
CPT2 Carnitine O-palmitoyltransferase 2, mitochondrial
Phosphoglycerate kinase 1 deficiency (PGK1) (OMIM 300653)XL
  • Cramping, particularly w/exercise
  • Exercise-induced myalgia
  • Pain
  • Progressive weakness
  • Rhabdomyolysis &/or ↑ serum CK
In PGK1 deficiency:
  • Hemolytic anemia
  • Intellectual disability
PGK1 Phosphoglycerate kinase 1
Phosphoglycerate mutase deficiency (GSDX) (OMIM 261670)AR
  • ↑ rhabdomyolysis &/or ↑ serum CK
  • Exercise-induced myalgia
  • Myoglobinuria
Disorders distinguished by enzymatic &
molecular genetic testing
PGAM2 Phosphoglycerate mutase 2
Lactate dehydrogenase deficiency (GSDXI) (OMIM 612933)AR
  • Exercise-induced myalgia
  • Exercise intolerance
  • Fatigue
  • Muscle cramps
  • Rhabdomyolysis
Disorders distinguished by enzymatic &
molecular genetic testing
LDHA L-lactate dehydrogenase A chain
1.

Liver glycogen phosphorylase is activated by liver phosphorylase b kinase (PhK).

2.

Disorders of gluconeogenesis include: fructose-1,6-bisphosphatase deficiency, pyruvate dehydrogenase complex deficiency, and glycogen storage disease type I.

3.

Other causes of non-genetic primary liver disease (e.g., hepatitis) can also be considered.

4.

Other storage (metabolic) diseases can also be considered.

5.

LCHAD may also be referred to as mitochondrial trifunctional protein deficiency.

6.

Glycogen storage disease type V may also be referred to as McArdle disease.

7.

Glycogen storage disease type VII may also be referred to as Tarui disease or phosphofructokinase deficiency.

8.

From: Phosphorylase Kinase Deficiency

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.